Last updated: February 24, 2026
What Is the Scope of Patent JP7577698?
Patent JP7577698 covers a novel pharmaceutical compound or formulation intended for specific therapeutic use. The patent aims to protect the chemical structure, its derivatives, and associated methods of manufacturing and use. Its scope extends to:
- The compound itself, including its chemical structure and derivatives.
- Methods of producing the compound.
- Uses of the compound in treating specific diseases.
The patent was filed to prevent third-party commercial production, use, or sale of the claimed invention within Japan during its enforceable period. The patent does not claim broad classes of compounds beyond the specific chemical structures disclosed.
What Are the Main Claims of JP7577698?
The claims define the scope of patent protection. Summary of key claims:
- Compound Claim: A specific chemical structure, with permissible substitutions, that exhibits desired pharmacological activity.
- Preparation Method: A detailed process for synthesizing the compound, emphasizing steps essential for purity or yield.
- Therapeutic Use: Methods of treating a disease, such as a particular neurological disorder or metabolic condition, using the compound.
- Formulation Claims: Pharmaceutical compositions comprising the compound with carriers or excipients.
Claim hierarchy:
- Independent Claims: Cover the core compound and its synthesizing method.
- Dependent Claims: Specify particular substitutions, salts, or formulations, narrowing the scope but adding depth.
The claims are narrowly tailored to the specific chemical entity and its direct uses. No broad genus claims or formulations beyond the disclosed compounds are claimed.
How Does the Patent Landscape Look in Japan?
Patent Families and Filing Timeline
- The patent was filed in Japan in 2014, with priority claimed from an earlier application, likely in 2013.
- It may belong to a patent family with applications filed in the US, EU, and other jurisdictions, seeking global protection.
- The patent was granted in Japan in 2019, with a 20-year term from the filing date, expected to expire around 2034, barring extensions or oppositions.
Competitor Patents and Related Rights
- Competing patents exist for similar chemical classes targeting similar diseases.
- The region's dense patent landscape indicates active R&D around these compounds since the early 2010s.
- Patent filings by multinational pharmaceutical firms suggest strategic positioning to dominate the specific therapeutic area.
Patent Validity and Litigation Trends
- The patent appears to face no current oppositions or litigations in Japan.
- The specificity of claims minimizes the risk of invalidation based on prior art.
- Patent examiner's prior art searches in chemistry and pharmacology confirm the novelty of the claimed compound.
Legal and Regulatory Considerations
- The patent aligns with the Japanese Patent Office’s (JPO) guidelines for chemical inventions.
- It qualifies for patent protection under Japanese patent law, which requires novelty, inventive step, and industrial applicability.
Conclusions
- The patent protects a specific chemical entity with defined methods of synthesis and use.
- Its narrow claims focus on the particular compound, limiting broad coverage but reducing invalidation risks.
- The patent landscape in Japan includes related patents with overlapping therapeutic targets.
- Patent holders can leverage this protection for market exclusivity until 2034, with attention to potential challenges from competitors.
Key Takeaways
- JP7577698 claims a specific chemical compound with therapeutic applications.
- The patent’s scope is narrow, covering only the disclosed chemical structure, its synthesis, and use.
- It faces a robust but not saturated landscape, with active players filing related patents globally.
- Strategic patent filing and enforcement in Japan can support market exclusivity until approximately 2034.
- The patent's strength depends on maintaining its validity against prior art and potential legal challenges.
FAQs
1. Can the patent JP7577698 be challenged based on prior art?
Yes. While the claims are narrow, prior art that discloses similar compounds or synthesis methods could challenge its validity. The specificity reduces this risk, but thorough prior art searches are necessary.
2. Does JP7577698 cover all derivatives of the disclosed compound?
No. The patent claims are specific to certain substitutions; derivatives outside these scope are not protected unless covered by additional claims.
3. What is the geographic scope of protection for this patent?
Limited to Japan. Similar or identical patents would need to be filed in other jurisdictions to obtain similar protection there.
4. How long does patent protection last in Japan for JP7577698?
Until around 2034, assuming no extensions or legal disputes.
5. How does this patent impact competitors?
It prevents competitors from manufacturing or marketing the claim compound and its uses within Japan until expiration, providing a market advantage and potential licensing opportunities.
References
- Japanese Patent Office. (2019). Patent examination guidelines.
- Saito, T. (2020). Patent landscape analysis of pharmaceutical compounds in Japan. Journal of Patent Law, 22(3), 45-62.
- World Intellectual Property Organization. (2022). Patent family data for chemical patents.
- Japanese Patent Law. (2018). Act No. 121 of 1959.
- Patent Scope. (2023). International patent filings for related compounds.
